Myriad Genetics Shares Are Trading Lower After the Company Announced That It Discontinued the Second Part of Its Study Due to the Disparities Between the GeneSight Group and Control Group.
Myriad Genetics Shares Are Trading Lower After the Company Announced That It Discontinued the Second Part of Its Study Due to the Disparities Between the GeneSight Group and Control Group.
萬基遺傳股票交易走低，公司宣佈由於GeneSight組和對照組之間的差異，停止了研究的第二部分。
Myriad Genetics Shares Are Trading Lower After the Company Announced That It Discontinued the Second Part of Its Study Due to the Disparities Between the GeneSight Group and Control Group.
萬基遺傳股票交易走低，公司宣佈由於GeneSight組和對照組之間的差異，停止了研究的第二部分。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間